Related Experiment Video
Updated: Aug 10, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
[A case of intravascular malignant lymphomatosis presenting as cerebral infarction]
T Satow1, S Nabeshima, N Yamazoe
1Department of Neurosurgery, Tenri Hospital, Japan.
Insights
Intravascular malignant lymphomatosis (IML) is a rare condition causing progressive dementia and cerebral infarction. Early diagnosis, often requiring brain biopsy, is crucial for potential treatment, though outcomes remain challenging.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Intravascular malignant lymphomatosis (IML) is a rare neoplastic disorder characterized by the proliferation of lymphoid cells within small blood vessels.
- Neurological manifestations are common in IML, often presenting as the primary clinical feature.
Observation:
- A previously healthy 62-year-old male presented with progressive dementia and multiple cerebral infarcts on MRI.
- The patient exhibited high fever, elevated C-reactive protein (CRP), lactate dehydrogenase (LDH), and soluble IL-2 receptor (sIL-2R).
- Initial muscle biopsy was inconclusive, but subsequent brain biopsy confirmed the diagnosis of IML.
Findings:
- Progressive dementia and multifocal cerebral infarctions are key indicators of IML.
- Elevated inflammatory markers (CRP) and lymphoma markers (LDH, sIL-2R) support the diagnosis.
- Brain biopsy is essential for definitive diagnosis when other methods are inconclusive.
Implications:
- This case highlights the importance of considering IML in patients with rapidly progressive dementia and unexplained multiple cerebral infarcts.
- Prompt diagnosis and treatment, though challenging, are critical for managing this rare condition.
- Further research into diagnostic strategies and therapeutic interventions for IML is warranted.
Abstract:
A case of intravascular malignant lymphomatosis (IML) presenting as progressive cerebral infarction is reported. A 62-year-old previously healthy male developed progressive dementia. MRI of the brain at the nearest hospital revealed multiple infarcts with unknown etiology. His level of consciousness deteriorated rapidly, and then he was transferred to our hospital for further evaluation. High grade fever, raised serum C reactive protein (CRP), and raised lymphoma markers (serum LDH and soluble IL-2 receptor (sIL-2R)) were observed. Repeated brain MRI disclosed progression of multifocal cerebral infarctions. We considered IML most likely, and we performed muscle biopsy. However muscle biopsy didn't demonstrate any proliferation of neoplastic cells of lymphoid origin within small vessels. Thereafter IML was diagnosed by brain biopsy. The patient underwent chemotherapy, but died of pneumonia due to severe myelosuppression. IML is a rare disease but most commonly shows neurological symptomatology as its clinical manifestation. Dementia is the most common neurological symptom, and progressive multiple infarction is the most common of the MRI findings. Rapidly progressive dementia associated with multiple infarction, when elevated CRP, LDH and sIL-2R are observed in the laboratory data, is suggestive of IML.
More Related Videos
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
07:14Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Brain Abscess l: Introduction